Discover 2,396 paid clinical trials in Annapolis, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,396
Active & Responsive
Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects
for
Ocular Hypertension, Suspect Glaucoma
Location: Baltimore MD, Columbia MD, Silver Spring MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18+
Code: NCT04401982
Recruiting
Active & Responsive
Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus
for
Chronic Hepatitis Delta
Location: Baltimore MD, New York NY, Louisville KY, La Jolla CA,
Sponsor: Gilead Sciences
Sex: All
Age: 18 - 69
Code: NCT07096193
Phase1, Phase2, Recruiting
Active & Responsive
TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B
for
Hepatitis B, Chronic Hepatitis B
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18+
Code: NCT04843852
Phase1, Recruiting
Active & ResponsiveNew
Study of Oral Food Challenge Biomarkers (SAFER)
for
Allergy
Location: Baltimore MD, New York NY, Palo Alto CA
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 1 - 17
Code: NCT07279467
Recruiting
Active & Responsive
Efficacy of Tezepelumab in Peanut Oral Immunotherapy
for
Peanut Allergy
Location: Baltimore MD, New York NY, Chapel Hill NC, Boston MA,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 12 - 55
Code: NCT07015996
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for
Breast Neoplasms
Location: Baltimore MD, Silver Spring MD, Fairfax VA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312176
Phase3, Recruiting
Active & Responsive
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface Disease in Pt w/ oGVHD
for
Dry Eye Disease, oGVHD
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18+
Code: NCT04946721
Recruiting
Active & Responsive
Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
for
Metastatic Colorectal Adenocarcinoma,
Location: Baltimore MD, Washington D.C. DC, Atlanta GA, Aurora CO
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07147231
Phase1, Phase2, Recruiting
Active & Responsive
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
for
Extensive Stage Lung Small Cell Carcinoma,
Location: Baltimore MD, Washington D.C. DC, Richmond VA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06287775
Phase1, Phase2, Recruiting
Active & Responsive
GCC 2546- Motion Management
for
Lung Cancer (NSCLC), Radiation
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18+
Code: NCT07398209
Recruiting
Active & Responsive
Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer
for
Carcinoma, Non-Small Cell Lung
Location: Baltimore MD, Washington D.C. DC
Sponsor: Georgetown University
Sex: All
Age: 18+
Code: NCT04499053
Phase2, Recruiting
Active & Responsive
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for
Prostate Cancer, Prostatic Neoplasms
Location: Baltimore MD, Washington D.C. DC, Philadelphia PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Male
Age: 18+
Code: NCT06925737
Phase3, Recruiting
Active & Responsive
Spinal Cord Injury Registry - North American Clinical Trials Network
for
Spinal Cord Injury
Location: Baltimore MD, Bethesda MD, Philadelphia PA,
Sponsor: Robert G. Grossman, MD
Sex: All
Age: 18+
Code: NCT00178724
Recruiting
Active & Responsive
MRgFUS Pallidotomy for the Treatment of Task Specific Focal Hand Dystonia (TSFD)
for
Task-Specific Focal Dystonia
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 21 - 70+
Code: NCT06367608
Recruiting
Active & Responsive
Acute Normovolemic Hemodilution on Urine Neutrophil Gelatinase-associated Lipocalin Levels
for
Acute Kidney Injury
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18 - 70
Code: NCT05349292
Recruiting
Active & Responsive
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer,
Location: Baltimore MD, Washington D.C. DC, Fairfax VA,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT06901531
Phase3, Recruiting
Active & Responsive
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
for
Alpha1-Antitrypsin Deficiency
Location: Baltimore MD, Hershey PA, Philadelphia PA, Richmond VA,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT05677971
Phase3, Recruiting
Active & Responsive
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
for
Obesity, Overweight and/or Obesity, Overweight
Location: Baltimore MD, Norfolk VA, New York NY, Greensboro NC,